OnKure Therapeutics, Inc. (OKUR) › Shareholders' EquityOnKure Therapeutics, Inc. (OKUR) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$23.13M2020: -$42.12M2021: $147.21M2022: -$54.42M2023: -$101.84M2024: $103.83M2025: $56.18M$56.18M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$56.18M-45.9%2024$103.83M+202.0%2023-$101.84M-87.1%2022-$54.42M-137.0%2021$147.21M+449.5%2020-$42.12M-82.1%2019-$23.13M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share